Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor necrosis factor receptor-associated protein 1 (TRAP1) is a mitochondrial chaperone belonging to the heat shock protein 90 (Hsp90) family. It plays a critical role in maintaining mitochondrial proteostasis, regulating reactive oxygen species (ROS) levels, and modulating apoptosis. TRAP1 is overexpressed in many tumor types and supports cancer cell survival under stress conditions. It has also been implicated in neurodegenerative diseases, particularly Parkinson's disease, where it protects against mitochondrial dysfunction.
Inhibition of TRAP1 activity to disrupt mitochondrial function and induce apoptosis in cancer cells. Modulation of TRAP1 phosphorylation to impact neuroprotection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Necrosis Factor Receptor-Associated Protein 1 (TRAP1).